Premium
Positional cloning of a cyromazine resistance gene in Drosophila melanogaster
Author(s) -
Chen Z.,
Robin C.,
Damiano J.,
Lydall J.,
Lumb C.,
Smith K.,
Blasetti A.,
Daborn P. J.,
Heckel D.,
McKenzie J. A.,
Batterham P.
Publication year - 2006
Publication title -
insect molecular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.955
H-Index - 93
eISSN - 1365-2583
pISSN - 0962-1075
DOI - 10.1111/j.1365-2583.2006.00622.x
Subject(s) - drosophila melanogaster , biology , genetics , cloning (programming) , gene , drosophila (subgenus) , positional cloning , insecticide resistance , resistance (ecology) , computational biology , toxicology , phenotype , ecology , computer science , programming language
Cyromazine is an effective insecticide used to control dipteran insects. Its precise mode of action is yet to be determined, although it has been suggested that it interferes with the hormone system, sclerotization of the cuticle, or nucleic acid metabolism. To understand the way in which cyromazine acts, we have positionally cloned a cyromazine resistance gene from Drosophila melanogaster . Six cyromazine resistance alleles had previously been generated by ethyl methanasulphonate treatment. Two of these failed to complement each other and here we identify them as having independent non‐sense mutations in CG32743 , which is an ortholog of Smg1 of worms and mammals and encodes a phosphatidylinositol kinase‐like kinase (PIKK). RNAi experiments confirm that cyromazine resistance can be achieved by knocking down CG32743 . These are the first cyromazine resistant mutations identified at the nucleotide level. In mammals Smg1 phosphorylates P53 in response to DNA damage. This finding supports the hypothesis that cyromazine interferes with nucleic acid metabolism.